Flaxseed and its derivative flaxseed oil/linseed oil are rich sources of the essential fatty acid alpha-linolenic acid, which is a biologic precursor to omega-3 fatty acids such as eicosapentaenoic acid. Although omega-3 fatty acids have been associated with improved cardiovascular outcomes, evidence from human trials is mixed regarding the efficacy of flaxseed products for coronary artery disease or hyperlipidemia.
The lignan constituents of flaxseed (not flaxseed oil) possesses in vitro anti-oxidant and possible estrogen receptor agonist/antagonist properties, prompting theories of efficacy for the treatment of breast cancer. However, there is not sufficient human evidence to make a recommendation. As a source of fiber mucilage, food additives oral flaxseed (not flaxseed oil) may possess laxative properties, although only one human trial has been conducted for this indication. In large doses, or when taken with inadequate water, flaxseed may precipitate bowel obstruction via a mass effect. The effects of flaxseed on blood glucose levels are not clear, although hyperglycemic effects have been reported in one case series.
Flaxseed oil contains only the alpha-linolenic acid component of flaxseed, and not the fiber or lignan components. Therefore, food oils may share the purported lipid-lowering properties of flaxseed, but not the proposed laxative or anti-cancer abilities.
No comments:
Post a Comment